Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/13/2008 | DE10107659B4 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
03/13/2008 | CA2663003A1 Compositions and methods for enhancing transport through mucus |
03/13/2008 | CA2662827A1 Novel soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations |
03/13/2008 | CA2662748A1 Liquid pharmaceutical formulations for oral administration of a cgrp antagonist |
03/13/2008 | CA2662710A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
03/13/2008 | CA2662607A1 Composition comprising reduced coenzyme q10 and lysolecithin |
03/13/2008 | CA2662434A1 Topical compositions |
03/13/2008 | CA2661930A1 Novel nanoparticles |
03/13/2008 | CA2661830A1 Dry powder compound formulations and uses thereof |
03/13/2008 | CA2661423A1 Disposable infusion device with automatic unlocking mechanism |
03/13/2008 | CA2660685A1 Aqueous formulation comprising an antitumor agent |
03/12/2008 | EP1897611A1 Process for producing microcapsule, microcapsule production apparatus and microcapsule sheet |
03/12/2008 | EP1897560A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
03/12/2008 | EP1897559A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
03/12/2008 | EP1897558A1 Solid preparation |
03/12/2008 | EP1897545A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
03/12/2008 | EP1897544A1 Opioid agonist and antagonist combinations |
03/12/2008 | EP1897543A1 Buprenorphine- wafer for drug substitution therapy |
03/12/2008 | EP1897542A1 Aqueous formulation comprising an antitumor agent |
03/12/2008 | EP1897538A1 Formulations for antigen-specific tolerance induction |
03/12/2008 | EP1897537A1 Composition comprising an angiotensin II receptor antagonist |
03/12/2008 | EP1897536A1 Surface cross-linked lipidic particles, methods of production and uses therefor |
03/12/2008 | EP1897535A1 Substitution fluid for haemofiltration |
03/12/2008 | EP1896076A2 Compositions and methods for enhancement of sexual function |
03/12/2008 | EP1896059A2 Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract |
03/12/2008 | EP1896056A1 Reinforced collagen scaffold |
03/12/2008 | EP1896051A2 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
03/12/2008 | EP1896038A1 Method and composition for transdermal drug delivery |
03/12/2008 | EP1896034A2 Micronized tanaproget compositions, and methods of preparing the same |
03/12/2008 | EP1896028A2 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy |
03/12/2008 | EP1896025A1 Scopolamine for the treatment of depression and anxiety |
03/12/2008 | EP1896021A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
03/12/2008 | EP1896016A2 Method for solubilizing metronidazole |
03/12/2008 | EP1896007A2 Method of administering a cationic liposomal preparation comprising paclitexel |
03/12/2008 | EP1896006A2 An entacapone-containging oral dosage form |
03/12/2008 | EP1896003A2 Parenteral selenomethionine for production of selenium-rich foods |
03/12/2008 | EP1895995A2 Multilayer drug system for the delivery of galantamine |
03/12/2008 | EP1895994A2 Multilayer drug delivery system with barrier against reservoir material flow |
03/12/2008 | EP1895993A1 Electrostatic patch for allergen screening and applicator for same |
03/12/2008 | EP1895992A2 Compressible gum based delivery systems for the release of ingredients |
03/12/2008 | EP1895991A2 Modified release formulations of anti-irritability drugs |
03/12/2008 | EP1895990A2 Formulations containing pantoprazole free acid and its salts |
03/12/2008 | EP1895989A2 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids |
03/12/2008 | EP1895988A2 Multi-reservoir implantable pump with variable flow rate capabilities |
03/12/2008 | EP1895987A2 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent |
03/12/2008 | EP1895986A2 Formulations of mast cell stabilizing agents for delivery to the colon |
03/12/2008 | EP1895985A1 Morphine sulphate formulations |
03/12/2008 | EP1895984A2 Nanoparticulate imatinib mesylate formulations |
03/12/2008 | EP1895983A2 Injectable compositions and process for preparation of such compositions |
03/12/2008 | EP1895982A2 Stable nanoparticle formulations |
03/12/2008 | EP1895981A1 Remineralizing oral and dental care and cleansing compositions |
03/12/2008 | EP1895960A1 Transdermal delivery of cannabinoids |
03/12/2008 | EP1845983A4 Ophthalmic compositions and methods of using the same |
03/12/2008 | EP1771157B1 Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form |
03/12/2008 | EP1758567A4 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
03/12/2008 | EP1658047B1 Spray-dried amorphous powder with a low residual moisture and excellent storage stability |
03/12/2008 | EP1648440B1 Semi-solid formulations for the oral administration of taxoids |
03/12/2008 | EP1622612B1 Pharmaceutical formulation of the sodium salt of telmisartan |
03/12/2008 | EP1524967B1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
03/12/2008 | EP1511469A4 Triggered start products and processes for the production and use thereof |
03/12/2008 | EP1494654B1 Palatable chewable tablet |
03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
03/12/2008 | EP1434590B1 Method for inhibiting the formation of seromas using factor xiii |
03/12/2008 | EP1427395B1 Stabilization of active agents by formulation into nanoparticulate form |
03/12/2008 | EP1411986B1 Composition comprising epigallocatechin gallate |
03/12/2008 | EP1408999B1 Compositions addressing inflammation and/or degenerative disorders |
03/12/2008 | EP1357896B1 Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same |
03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
03/12/2008 | EP1292611B1 Glycopeptide carboxy-saccharide derivatives |
03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
03/12/2008 | EP1107730B1 Medicated chewing gum delivery system for nicotine |
03/12/2008 | CN201033171Y Medicine label for treating arthralgia |
03/12/2008 | CN201033170Y Split combination type transparent medicine label |
03/12/2008 | CN101141978A Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
03/12/2008 | CN101141971A Stabilised plant extract and its therapeutic use |
03/12/2008 | CN101141963A Pellet-type controlled-release preparation for combating vertigo |
03/12/2008 | CN101141962A Tablet-type controlled-release preparation for combating vertigo |
03/12/2008 | CN101141961A Stable particular pharmaceutical composition of solifenacin or salt thereof |
03/12/2008 | CN101141953A Crystallization inhibitor and its use in gelatin capsules |
03/12/2008 | CN101141952A New soft capsules |
03/12/2008 | CN101141951A Sublingual coated tablet |
03/12/2008 | CN101141950A Pharmaceutical forms with improved pharmacokinetic properties |
03/12/2008 | CN101141949A New pharmaceutical compositions useful in the treatment of parkinson's disease |
03/12/2008 | CN101141948A Drug delivery compositions and related methods |
03/12/2008 | CN101139384A 5-peptide derivative, preparation method and use thereof |
03/12/2008 | CN101139281A Nano calcium lactate and method for making same |
03/12/2008 | CN101138636A Gene medicine conveying system and method of preparing the same |
03/12/2008 | CN101138631A Novel recombinant parathyroid hormone (1-34) correlated peptide nose drops |
03/12/2008 | CN101138629A Recombinant human keratinocyte growth factor-2 freeze dried agent |
03/12/2008 | CN101138626A Bone-through ache-treating emplastrum |
03/12/2008 | CN101138622A Prescription of mouth ulcer bilayer film and technique of preparing the same |
03/12/2008 | CN101138617A Multiple-effect paste for activating blood circulation and removing stasis |
03/12/2008 | CN101138611A Compound radiating empyrosis aerosol |
03/12/2008 | CN101138609A Prescription of Chinese yam lozenge |
03/12/2008 | CN101138607A Sea snake bining sugar-coating tablets and preparation method thereof |
03/12/2008 | CN101138603A Pure Chinese traditional medicine granular preparation for treating gastroesophageal reflux disease |
03/12/2008 | CN101138602A Kidney-nourishing gout-treating capsule |
03/12/2008 | CN101138601A Preparation method of Chinese herb medicine compound for treating coronary heart disease |
03/12/2008 | CN101138600A Wound quick-healing medicine |